Plunkett Research Online: Astellas Pharma Inc

ASTELLAS PHARMA INC (ALPMY:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Astellas Pharma, Inc. is one of the largest pharmaceutical manufacturers in Japan. The company’s current main products for the global market include: XTANDI and Eligard, each for the treatment of prostate cancer; Betanis/Myrbetriq/BETMIGA and Vesicare, each for the treatment of overactive bladder (.....



Astellas Pharma Inc
Ticker: ALPMY
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 81-3-3244-3000
Fax:
Address: 2-5-1, Nihonbashi-Honcho
Chuo-ku
Tokyo, 103-8411 Japan

Types Of Business
Industry Ranks

Industry NAICS code:

Drugs, Manufacturing
Immunological Pharmaceuticals
Over-the-Counter Products
Reagents
Genomic Research
Venture Capital
Drug Licensing
ContactsDescription

Kenjl YasukawaCEO/Pres.
Naoki OkamuraCFO/Chief Strategy Officer
See More
Astellas Pharma, Inc. is one of the largest pharmaceutical manufacturers in Japan. The company’s current main products for the global market include: XTANDI and Eligard, each for the treatment of prostate cancer; Betanis/Myrbetriq/BETMIGA and Vesicare, each for the treatment of overactive bladder (.....See More See More

Auditor: Ernst & Young ShinNihon LLC
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202020192018201720162015
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Audentes Therapeutics Inc
Nanna Therapeutics Limited
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: